0.8408
price up icon1.30%   0.0108
after-market Handel nachbörslich: .83 -0.0108 -1.28%
loading

Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
32.20%
0.1524
0.2247 0.2904 0.2933 0.3555
Operating Expenses
44.46%
3.9759
7.1579 6.4709 5.5856 7.0221
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
44.46%
3.9759
7.1579 6.4709 5.5856 7.0221
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
44.85%
-3.8235
-6.9332 -6.1805 -5.2924 -6.6665
Net Interest Income/Expense
32.20%
0.1524
0.2247 0.2904 0.2933 0.3555
Nonoperating Income/Loss
105.46%
0.00335
-0.0614 0.0154 -0.0122 0.00269
Income/Loss From Continuing Operations Before Tax
32.20%
0.1524
0.2247 0.2904 -5.0113 -6.3083
Income/Loss From Continuing Operations After Tax
45.82%
-3.6678
-6.7699 -5.8747 -5.0113 -6.3083
Net Income/Loss
45.82%
-3.6678
-6.7699 -5.8747 -5.0113 -6.3083
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
15.97
- 15.97 15.97 15.97
Diluted Average Shares
15.97
- 15.97 15.97 15.97
Basic Earnings Per Share
45.24%
-0.23
-0.42 -0.37 -0.31 -0.40
Diluted Earnings Per Share
45.24%
-0.23
-0.42 -0.37 -0.31 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):